Vericel (VCEL) Research & Development (2010 - 2026)
Vericel (VCEL) posted Research & Development of $7.49 million for Q2 2026, up 11.3% from $6.73 million a year earlier but down 7.5% from the prior quarter.
Powered by 
Analysis
Vericel (VCEL) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Vericel was $29.17 million, up 16.6% year-over-year; for FY2025, it came in at $27.56 million, up 11.2% from FY2024.
- Annual Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
- In prior years, Vericel's Research & Development was $24.8 million in FY2024 (+17.8%), $21.04 million in FY2023 (+5.5%), $19.94 million in FY2022 (+22.4%) and $16.29 million in FY2021 (+25.1%).
- Quarterly Research & Development has run from a low of $3.92 million in Q4 2021 to a high of $8.1 million in Q1 2026 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last four quarters, with growth averaging 10.8% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2025, with growth of 47.3%; the weakest was Q2 2025, with a decline of 8.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $8.1 million (Q1 2026), $7.25 million (Q4 2025) and $6.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Vericel | 2.06 Bn | 1.48 Bn | 56.40 Mn | 7.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.49 Mn |
| Mar 31, 2026 | 8.10 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 6.32 Mn |
| Jun 30, 2025 | 6.73 Mn |
| Mar 31, 2025 | 7.26 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 7.36 Mn |
| Mar 31, 2024 | 6.42 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Sep 30, 2023 | 5.68 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Mar 31, 2023 | 5.21 Mn |
| Dec 31, 2022 | 5.25 Mn |
| Sep 30, 2022 | 5.05 Mn |
| Jun 30, 2022 | 4.79 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 3.92 Mn |
| Sep 30, 2021 | 4.28 Mn |
API Access
Vericel Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();